51cg

Dr Carl Counsell

In this section
Dr Carl Counsell
Dr Carl Counsell
Dr Carl Counsell

MRCP, MSc, MD

Reader (Clinical)

51cg
Email Address
carl.counsell@abdn.ac.uk
Office Address

Room 1:009, Polwarth Building Division of Applied Health Sciences 51cg Foresterhill Aberdeen AB25 2ZD

School/Department
School of Medicine, Medical Sciences and Nutrition

Biography

Carl is a clinical reader and honorary consultant in neurology.  He graduated in medicine from Cambridge University in 1988, did his early postgraduate medical training in London, Newcastle and Falkirk and then trained in neurology, stroke and epidemiology in Edinburgh.  He spent a year in Melbourne where he specialised in movement disorders before taking up his present post in 2001.  A committed Christian, he would like to have more time to serve in his church and develop his interests in Fairtrade and conservation. 

Latest Publications

  • Personalised prediction of institutionalisation in Parkinson’s: prognostic factor identification and model development and validation using IPD meta-analysis

    Li, Y., McLernon, D., Lawson, R. A., Yarnall, A. J., Bäckström, D., Forsgren, L., Camacho, M., Williams-Gray, C. H., Maple-Grodem, J., Alves, G., Tysnes, O., Counsell, C., MacLeod, A., Parkinson’s Incidence Cohorts Collaboration
    Parkinsonism and Related Disorders, vol. 149, 108390
    Contributions to Journals: Articles
  • Prognosis in Parkinson’s disease: an individual-patient-data meta-analysis of six European incidence cohorts

    MacLeod, A., McLernon, D., Camacho, M., Williams-Gray, C. H., Lawson, R. A., Yarnall, A. J., Bäckström, D., Forsgren, L., Maple-Grødem, J., Alves, G., Tysnes, O., Counsell, C., Parkinson’s Incidence Cohorts Collaboration
    Movement Disorders, vol. 41, no. 7, pp. 1798-1811
    Contributions to Journals: Articles
  • Multi-locus genetic dosage shapes cognitive disease progression in Parkinson’s patients: 15-year meta-analysis of 24 cohorts

    Kang, X., Lin, Z., Calikusu, F. Z., Miller, L. A., Soriano, S., Locascio, J. J., Corvol, J., Maple-Grødem, J., Fan, Y., Mead, K., Campbell, M. C., Elbaz, A., Lesage, S., Brice, A., Hung, A. Y., Schwarzschild, M. A., Hayes, M. T., Wills, A., Herrington, T. M., Liu, G., Ravina, B., Taba, P., Kõks, S., Simuni, T., Forsgren, L., Counsell, C., Macleod, A. D., Beach, T. G., Alves, G., Tysnes, O., Perlmutter, J. S., Heutink, P., Kasten, M., Mollenhauer, B., Trenkwalder, C., Klein, C., Hepp, D. H., Backstrom, D., Svenningsson, P., Hu, M. T., Williams-Gray, C. H., Barker, R. A., Scherzer, C. R., International Genetics of Parkinson Disease Progression (IGPP) Consortium
    npj Parkinson's Disease
    Contributions to Journals: Articles
  • Digitally enabled therapy for chronic tic disorders and Tourette Syndrome: a systematic review and economic evaluation

    Boyers, D., Cruickshank, M., Azharuddin, M., Manson, P., Swallow, D., Counsell, C., Brazzelli, M.
    Health Technology Assessment, vol. 30, no. 8
    Contributions to Journals: Articles
  • Systematic review of prognostic models in Parkinson’s disease

    Li, Y., McDonald-Webb, M., McLernon, D., Counsell, C., MacLeod, A.
    npj Parkinson's Disease, vol. 11, 266
    Contributions to Journals: Articles

View My Publications

Research

Research Overview

Carl is a consultant neurologist with subspecialty interest in movement disorders.  His main research interests are in evidence-based medicine and broader aspects of clinical epidemiology such as incidence and prognostic studies, particularly in relation to Parkinson's disease, other movement disorders and stroke.  His team have established several cohorts of parkinsonian patients for long-term follow-up and supported a number of non-industry sponsored clinical trials and Cochrane reviews, whilst also trying to promote multidisciplinary neurology research in Aberdeen. 

Research Specialisms

  • Clinical Medicine

Our research specialisms are based on the Higher Education Classification of Subjects (HECoS) which is , published under the licence.

Current Research

The PINE study: a population-based incidence cohort of people with Parkinson's disease and other parkinsonian disorders, along with their carers and controls who are being followed up lifelong to establish long-term prognosis.

The Parkinson's Incidence Cohorts Collaboration:  an individual patient data meta-analysis of all population- based incidence cohorts of Parkinson's disease to assess prognosis and allow prognostic modelling.     

The Scottish PSP/CBD prevalence cohort:  a cohort of people with two related Parkinson's plus disorders,  Progressive Supranuclear Palsy and Corticobasal Degeneration as well as Parkinson's disease controls, to assess diagnostic and care pathways and prognosis.  

 

Past Research

Cochrane systematic reviews of randomised trials in stroke care and Parkinson's disease

Prognostic modelling in acute stroke

Incidence of Parkinson's disease and other parkinsonian disorders in North-East Scotland 

Prevalence of multiple sclerosis in North-East Scotland and northern isles

Randomised trial of physiotherapy for cervical dystonia

 

Knowledge Exchange

Member of Parkinson's Excellence Network

Collaborations

Cochrane Collaboration Stroke Review Group, Professors Charles Warlow and Peter Sandercock, University of Edinburgh, UK, 1993-98.

Scottish Audit of Intracranial Vascular Malformations, Professor Rustam Al-Shahi Salman, University of Edinburgh, UK, 2002-2014. 

PDMED trial, Professor Carl Clarke, University of Birmingham, UK, 2004-2020.

Clinical trial methods in neurodegenerative diseases, Professor John Zajicek, University of Plymouth, UK, 2009-2014. 

PDCOMM trial, Professor Sackley, University of Nottingham, UK, 2016-2023.

NICE technology appraisals for multiple sclerosis, Universities of Warwick and Exeter, UK, 2016-2022 

Parkinson's Incidence Cohorts Collaboration, Professor Tysnes, Dr Guido Alves, Professor Lars Forsgren, Dr Caroline Williams-Gray, Dr Alison Yarnall, Universities of Stavanger (Norway), Umea (Sweden), Cambridge (UK) and Newcastle (UK), 2018 ongoing 

PD Connect exercise trial, Julie Jones, Robert Gordon University, Aberdeen, UK, 2019-2022 

 

Supervision

Dr Kate Taylor (MD), 2002-06, Incidence and prognosis of parkinsonism in north-east Scotland: a pilot study.

Clare Harris (MSc), 2006-08, PINE participants attitudes to brain donation. 

Dr Robert Caslake (PhD), 2006-11, Incidence and short-term prognosis of Parkinson's disease and other parkinsonian disorders in north-east Scotland.

Dr Elizabeth Visser (MD), 2009-13, Prevalence of multiple sclerosis in northern Scotland.

Dr David McGhee (PhD), 2009-13, Improving clinical trial design in neurodegenerative diseases.

Dr Angus Macleod (PhD), 2012-15, Predicting mortality and dependency in Parkinson's disease.

Dr Diane Swallow (PhD), 2016-21, Assessing diagnostic pathways in progressive supranuclear palsy and corticobasal degeneration.

Funding and Grants

Research funding has been obtained from:

Parkinson’s UK, Scottish Chief Scientist Office, BMA Doris Hillier award, RS Macdonald Trust, BUPA Foundation, NHS Grampian endowments, Dystonia Society, National Institute for Health Research.  

Teaching

Teaching Responsibilities

Lectures and clinical teaching of neurology for medical and dental students.

Supervising medical student elective and MSc projects 

Non-course Teaching Responsibilities

Regent to medical students

Publications

Page 1 of 8 Results 1 to 25 of 199

  • Personalised prediction of institutionalisation in Parkinson’s: prognostic factor identification and model development and validation using IPD meta-analysis

    Li, Y., McLernon, D., Lawson, R. A., Yarnall, A. J., Bäckström, D., Forsgren, L., Camacho, M., Williams-Gray, C. H., Maple-Grodem, J., Alves, G., Tysnes, O., Counsell, C., MacLeod, A., Parkinson’s Incidence Cohorts Collaboration
    Parkinsonism and Related Disorders, vol. 149, 108390
    Contributions to Journals: Articles
  • Prognosis in Parkinson’s disease: an individual-patient-data meta-analysis of six European incidence cohorts

    MacLeod, A., McLernon, D., Camacho, M., Williams-Gray, C. H., Lawson, R. A., Yarnall, A. J., Bäckström, D., Forsgren, L., Maple-Grødem, J., Alves, G., Tysnes, O., Counsell, C., Parkinson’s Incidence Cohorts Collaboration
    Movement Disorders, vol. 41, no. 7, pp. 1798-1811
    Contributions to Journals: Articles
  • Multi-locus genetic dosage shapes cognitive disease progression in Parkinson’s patients: 15-year meta-analysis of 24 cohorts

    Kang, X., Lin, Z., Calikusu, F. Z., Miller, L. A., Soriano, S., Locascio, J. J., Corvol, J., Maple-Grødem, J., Fan, Y., Mead, K., Campbell, M. C., Elbaz, A., Lesage, S., Brice, A., Hung, A. Y., Schwarzschild, M. A., Hayes, M. T., Wills, A., Herrington, T. M., Liu, G., Ravina, B., Taba, P., Kõks, S., Simuni, T., Forsgren, L., Counsell, C., Macleod, A. D., Beach, T. G., Alves, G., Tysnes, O., Perlmutter, J. S., Heutink, P., Kasten, M., Mollenhauer, B., Trenkwalder, C., Klein, C., Hepp, D. H., Backstrom, D., Svenningsson, P., Hu, M. T., Williams-Gray, C. H., Barker, R. A., Scherzer, C. R., International Genetics of Parkinson Disease Progression (IGPP) Consortium
    npj Parkinson's Disease
    Contributions to Journals: Articles
  • Digitally enabled therapy for chronic tic disorders and Tourette Syndrome: a systematic review and economic evaluation

    Boyers, D., Cruickshank, M., Azharuddin, M., Manson, P., Swallow, D., Counsell, C., Brazzelli, M.
    Health Technology Assessment, vol. 30, no. 8
    Contributions to Journals: Articles
  • Systematic review of prognostic models in Parkinson’s disease

    Li, Y., McDonald-Webb, M., McLernon, D., Counsell, C., MacLeod, A.
    npj Parkinson's Disease, vol. 11, 266
    Contributions to Journals: Articles
  • Beta-adrenoceptor drugs and progression to Parkinson's disease milestones in a large pooled incident cohort

    Wijeyekoon, R. S., Camacho, M., Bäckström, D., Forsgren, L., Lawson, R. A., Yarnall, A. J., Macleod, A. D., Counsell, C. E., Tysnes, O., Alves, G., Maple-Grødem, J., Barker, R. A., Williams-Gray, C. H., Parkinson’s Incidence Cohorts Collaboration
    npj Parkinson's Disease, vol. 11, no. 1, pp. 198
    Contributions to Journals: Articles
  • Dementia Risk Prediction in Early Parkinson's Disease: Validation and Genetic Integration of the Montreal Parkinson risk of dementia scale (MoPaRDS)

    Szwedo, A. A., Dalen, I., Lawson, R. A., Yarnall, A. J., Pedersen, K. F., MacLeod, A., Counsell, C., Bäckström, D., Forsgren, L., Camacho, M., Williams-Gray, C. H., Tysnes, O., Alves, G., Maple-Grødem, J., Parkinson’s Incidence Cohorts Collaboration
    Journal of Parkinson's Disease, vol. 15, no. 4, pp. 868-878
    Contributions to Journals: Articles
  • Accuracy of routinely collected hospital administrative discharge data and death certificate ICD-10 diagnostic coding in progressive supranuclear palsy and corticobasal syndrome: a systematic review and validation study

    Swallow, D., Counsell, C.
    Journal of Neurology, vol. 271, pp. 2929-2937
    Contributions to Journals: Articles
  • Total Patient Delay: A comparison of patient and clinician/health system delays in the diagnosis of progressive supranuclear palsy and corticobasal syndrome

    Swallow, D., Murchie, P., Counsell, C.
    Movement Disorders Clinical Practice, vol. 11, no. 5, pp. 478-487
    Contributions to Journals: Articles
  • Incidence and risk factors of institutionalisation in Parkinson's disease and atypical parkinsonism

    Li, Y., McLernon, D. J., Counsell, C. E., Macleod, A. D.
    Parkinsonism & Related Disorders, vol. 118
    Contributions to Journals: Articles
  • Progressive multifocal leukoencephalopathy associated with carbamazepine -: induced immune dysfunction and recovery after carbamazepine cessation

    Perrott, S., Khan, Q. I., Counsell, C. E., Macleod, A. D.
    BMJ Case Reports, vol. 16, no. 7, e255119
    Contributions to Journals: Articles
  • The evolution of diagnosis from symptom onset to death in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) compared to Parkinson’s disease (PD)

    Swallow, D. M. A., Counsell, C. E.
    Journal of Neurology, vol. 270, pp. 3464-3474
    Contributions to Journals: Articles
  • Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia

    Gonzalez, M. C., Tovar-Rios, D. A., Alves, G., Dalen, I., Williams-Gray, C. H., Camacho, M., Forsgren, L., Bäckström, D., Lawson, R. A., Macleod, A. D., Counsell, C. E., Paquet, C., DeLena, C., D'Antonio, F., Pilotto, A., Padovani, A., Blanc, F., Falup-Pecurariu, C., Lewis, S. J., Rejdak, K., Papuc, E., Hort, J., Nedelska, Z., O'Brien, J., Bonanni, L., Marquié, M., Boada, M., Pytel, V., Abdelnour, C., Alcolea, D., Beyer, K., Tysnes, O. B., Aarsland, D., Maple-Grødem, J.
    Movement Disorders Clinical Practice, vol. 10, no. 6, pp. 980-986
    Contributions to Journals: Articles
  • Achieving proportionate governance review in Scotland: Threats and solutions

    Swallow, D. M., Counsell, C. E.
    Journal of the Royal College of Physicians of Edinburgh, vol. 53, no. 1, pp. 74-79
    Contributions to Journals: Comments and Debates
  • Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals?: A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis

    Armoiry, X., Wang-Steverding, X., Connock, M., Grove, A., Clarke, A., Arun, T., Counsell, C., Auguste, P.
    International Journal of Technology Assessment in Health Care, vol. 38, no. 1, pp. e83
    Contributions to Journals: Review articles
  • The incidence, baseline predictors and outcomes of dementia in an incident cohort of Parkinson’s disease and controls

    Counsell, C., Giuntoli, C., Khan, Q. I., Maple-Grodem, J., MacLeod, A.
    Journal of Neurology, vol. 269, pp. 4288–4298
    Contributions to Journals: Articles
  • Systematic review of prevalence studies of progressive supranuclear palsy and corticobasal syndrome

    Swallow, D., Syzheng, C., Counsell, C.
    Movement Disorders Clinical Practice, vol. 9, no. 5, pp. 604-613
    Contributions to Journals: Articles
  • Management of the first stage of convulsive status epilepticus in adults: a systematic review of current randomised evidence

    Cruickshank, M., Imamura, M., Counsell, C., Aucott, L., Manson, P., Booth, C., Scotland, G., Brazzelli, M.
    Journal of Neurology, vol. 269, no. 7, pp. 3420-3429
    Contributions to Journals: Review articles
  • Prevalence of progressive supranuclear palsy and corticobasal syndrome in Scotland

    Swallow, D., Counsell, C.
    Neuroepidemiology, vol. 56, no. 4, pp. 291–297
    Contributions to Journals: Articles
  • GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10-Year Population-Based Study

    Szwedo, A. A., Dalen, I., Pedersen, K. F., Camacho, M., Bäckström, D., Forsgren, L., Tzoulis, C., Winder-Rhodes, S., Hudson, G., Liu, G., Scherzer, C. R., Lawson, R. A., Yarnall, A. J., Williams-Gray, C. H., Macleod, A. D., Counsell, C. E., Tysnes, O., Alves, G., Maple-Grødem, J., Parkinson’s Incidence Cohorts Collaboration
    Movement Disorders, vol. 37, no. 5, pp. 1016-1027
    Contributions to Journals: Articles
  • Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis

    Cruickshank, M., Imamura, M., Booth, C., Aucott, L., Counsell, C., Manson, P., Scotland, G., Brazzelli, M.
    Health technology assessment (Winchester, England), vol. 26, no. 20, pp. 1-76
    Contributions to Journals: Articles
  • Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial

    Gray, R., Patel, S., Ives, N., Rick, C., Woolley, R., Muzerengi, S., Gray, A., Jenkinson, C., McIntosh, E., Wheatley, K., Williams, A., Clarke, C. E., PD MED Collaborative Group, Counsell, C.
    JAMA Neurology, vol. 79, no. 2, pp. 131-140
    Contributions to Journals: Articles
  • Lack of Association Between GBA Mutations and Motor Complications in European and American Parkinson's Disease Cohorts

    Maple-Grodem, J., Paul, K. C., Dalen, I., Ngo, K. J., Wong, D., Macleod, A. D., Counsell, C. E., Backstrom, D., Forsgren, L., Tysnes, O., Kusters, C. D. J., Fogel, B. L., Bronstein, J. M., Ritz, B., Alves, G.
    Journal of Parkinson's Disease, vol. 11, no. 4, pp. 1569-1578
    Contributions to Journals: Articles
  • First delirium episode in Parkinson’s disease and parkinsonism: incidence, predictors and outcomes

    Green, S., Perrott, S., McCleary, A., Sleeman, I., Maple-Grodem, J., Counsell, C., MacLeod, A.
    npj Parkinson's Disease, vol. 7, no. 1, 92
    Contributions to Journals: Articles
  • Ocrelizumab not recommended in France for patients with primary progressive multiple sclerosis while recommended in England: a review comparing the assessment by HAS and NICE

    Armoiry, X., Späth, H., Henaine, A., Dussart, C., Counsell, C., Connock, M.
    Expert opinion on biological therapy, vol. 21, no. 6, pp. 741-747
    Contributions to Journals: Review articles
Show 10 | 25 | 50 | 100 results per page

Refine

Chapters in Books, Reports and Conference Proceedings

Contributions to Journals

Contributions to Specialist Publications